TMCnet News
Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceNEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that Jeremey Levin, DPhil, MB, BChir, Chairman and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10, 2019 at 9:30 a.m. EDT. In addition, Dr. Levin will give a keynote address entitled “The State of the Biotechnology Sector Going into an Election Year” on Tuesday, September 10, at 1:00 p.m. EDT. The conference will be held at the Lotte New York Palace Hotel in New York City. A live audio webcast of the presentation can be accessed through the Events & Presentations section of the company's website at investors.ovidrx.co. An archived replay of the webcast will be available on the company's website for two weeks following the live presentation. About Ovid Therapeutics For more information on Ovid, please visit http://www.ovidrx.com/. Contacts Investors and Media: Or Investors: Media: |